Check-Cap Ltd. Revenue and Competitors

Isfiya, Israel

Location

$99.9M

Total Funding

Estimated Revenue & Valuation

  • Check-Cap Ltd.'s estimated annual revenue is currently $21.3M per year.(i)
  • Check-Cap Ltd.'s estimated revenue per employee is $251,000
  • Check-Cap Ltd.'s total funding is $99.9M.

Employee Data

  • Check-Cap Ltd. has 85 Employees.(i)
  • Check-Cap Ltd. grew their employee count by -29% last year.

Check-Cap Ltd.'s People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
VP QA&RAReveal Email/Phone
4
VP Clinical AffairsReveal Email/Phone
5
VP R&DReveal Email/Phone
6
Director Clinical AffairsReveal Email/Phone
7
HR ManagerReveal Email/Phone
8
System ManagerReveal Email/Phone
9
V&V Manager & System EngineerReveal Email/Phone
10
Operation QA ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$21.1M840%N/AN/A
#2
$5.6M450%$91.1MN/A
#3
$202.8M577-2%$632.9MN/A
#4
$21.3M85-29%$99.9MN/A
#5
$21.1M842%$128MN/A
#6
$22.3M891%N/AN/A
#7
$6.8M27-4%N/AN/A
#8
$5.8M23-12%N/AN/A
#9
$3.3M130%N/AN/A
#10
$1.3M50%N/AN/A
Add Company

What Is Check-Cap Ltd.?

Check-Cap is advancing the development of C-Scanᅢツᅡᆴ, the first and only preparation-free ingestible scanning capsule for the prevention of colorectal cancer (CRC) through the detection of precancerous polyps. The patient-friendly test has the potential to increase screening adherence and reduce the overall incidence of CRC. The C-Scanᅢツᅡᆴ system is comprised of an x-ray scanning capsule that communicates with a tracking and recording unit as well as proprietary software to generate 3D maps of the inner lining of the colon for the detection of precancerous polyps and other lesions. Please view our notice here: http://www.check-cap.com/legal-notice

keywords:N/A

$99.9M

Total Funding

85

Number of Employees

$21.3M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Check-Cap Ltd. News

2022-04-20 - These Two Small Cap Emerging Businesses Funds Are Good For Investment, Check Details

The fund has 98.51% investment in equities of which 69.01% in small-cap stocks. The fund's top holdings are in KPR Mills Ltd., Balrampur Chini...

2022-04-06 - Zacks Investment Research Upgrades Check-Cap (NASDAQ ...

According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging...

2022-03-30 - Check-Cap Reports Fourth Quarter and Full Year 2021 ...

ISFIYA, Israel, April 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ),...

2021-11-22 - Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan®

ISFIYA, Israel, Nov. 22, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps be ...

2021-11-02 - Check-Cap Announces Grant of Patent Covering C-Scan's Proprietary Tracking Technology in the U.S. and Additional Major Market Territories

ISFIYA, Israel, Nov. 2, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps befo ...